Intravenous gamma-globulin treatment and retreatment in Kawasaki disease

Pediatric Infectious Disease Journal

Volumn 17, Issue 12, 1998, Pages 1144-1148

  Burns, Jane C ^a   Capparelli, Edmund V ^a   Brown, Jennifer A ^a   Newburger, Jane W ^b   Glode, Mary P ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD UNIVERSITY   (United States)

^c Children's Hospital Colorado   (United States)

Author keywords

Aspirin; Coronary artery aneurysm; Pediatric cardiology; Vasculitis

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RETREATMENT; SCHOOL CHILD; TREATMENT FAILURE;

CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NORTH AMERICA; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032411505     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199812000-00009     Document Type: Article

References (10)

1. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7.
2. Newburger JW, Takahashi M, Beiser AS, et al. Single infusion of intravenous gamma globulin compared to four daily doses in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
3. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 1993;123:657-9.
4. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996;123:146-9.
5. Burns JC, Glode MP, Capparelli E, Brown JA, Newburger JW and the US/Canadian Kawasaki Syndrome Study Group. Intravenous gamma globulin treatment in Kawasaki syndrome: are all brands equal? In: Kato H, ed. Kawasaki disease: Proceedings of the Fifth International Kawasaki Disease Symposium, Fukuoka, Japan, May, 1995. Amsterdam: Elsevier Press, 1995:296-300.
6. Beiser AS, Takahashi M, Baker AL, Newburger JW and the U. S. Multicenter Kawasaki Study Group. A predictive instrument for coronary aneurysms. In: Kato H, ed. Kawasaki disease: Proceedings of the Fifth International Kawasaki Disease Symposium, Fukuoka, Japan, May, 1995. Amsterdam: Elsevier Press, 1995:339-42.
7. Rosenfeld EA, Corydon KD, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126: 524-9.
8. Durongpistkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-61.
9. Newburger JW. Treatment of Kawasaki disease. Lancet 1996;347:1128.
10. Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 1992;120:926-8.